NCT07007130View on ClinicalTrials.gov

Effect of Intraperitoneal Insulin Administration After Laparoscopy in Insulin-Resistant Patients on Prevention of Postoperative Adhesion Recurrence: A Randomized Controlled Trial

NANot yet recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2026

Conditions

Prevention of Postoperative Adhesions

Interventions

DRUG

Actrapid insulin

0.1 IU/kg of short-acting human insulin diluted in 100 mL of normal saline, instilled intraperitoneally before closure

DRUG

Normal saline

100 mL normal saline intraperitoneally

All Listed Sponsors

lead

Ain Shams University

OTHER

NCT07007130 - Effect of Intraperitoneal Insulin Administration After Laparoscopy in Insulin-Resistant Patients on Prevention of Postoperative Adhesion Recurrence: A Randomized Controlled Trial | Biotech Hunter | Biotech Hunter